SOCS3 promotes apoptosis of mammary differentiated cells

被引:23
|
作者
Le Provost, F [1 ]
Miyoshi, K
Vilotte, JL
Bierie, B
Robinson, GW
Hennighausen, L
机构
[1] NIDDK, Lab Genet & Physiol, NIH, Bethesda, MD 20892 USA
[2] INRA, Lab Genet Biochim & Cytogenet, F-78350 Jouy En Josas, France
关键词
mammary gland; suppressor of cytokine signalling; differentiation; involution; stromal adipocyte; epithelial cell; gene expression; prolactin; JAK/STAT pathway;
D O I
10.1016/j.bbrc.2005.10.138
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Growth and function of the mammary gland is regulated by cytokines and modulated by suppressor of cytokine signalling (SOCS) proteins. In vitro experiments demonstrated that SOCS3 can inhibit PRL induction of milk protein gene expression and STAT5 activation. We explored the SOCS3 expression pattern during mouse mammary development and its regulation by PRL and GH in wild-type and STAT5a-null mammary tissue. Our results suggest that, in vivo, PRL stimulates SOCS3 expression in stromal adipocytes, independently of STAT5a stimulation. In mammary epithelial cells, SOCS3 expression appears to be related to STAT3 activation. Together, our results are consistent with a role of SOCS3 in the mammary gland by promoting apoptosis of differentiated cells (adipocytes during gestation and epithelial cells during involution). (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1696 / 1701
页数:6
相关论文
共 50 条
  • [31] IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3
    Croker, Ben A.
    Kiu, Hiu
    Pellegrini, Marc
    Toe, Jesse
    Preston, Simon
    Metcalf, Donald
    O'Donnell, Joanne A.
    Cengia, Louise H.
    McArthur, Kate
    Nicola, Nicos A.
    Alexander, Warren S.
    Roberts, Andrew W.
    IMMUNOLOGY AND CELL BIOLOGY, 2012, 90 (01): : 124 - 129
  • [32] IL-6 PROMOTES ACUTE AND CHRONIC INFLAMMATORY DISEASE IN THE ABSENCE OF SOCS3
    Croker, B. A.
    Kiu, H.
    Metcalf, D.
    O'Donnell, J.
    Cengia, L.
    Alexander, W. S.
    Roberts, A. W.
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (09) : S51 - S52
  • [33] SOCS3 inhibits pathologic angiogenesis
    Joyal, Jean-Sebastien
    Stahl, Andreas
    Sun, Ye
    Shao, Zhuo
    Fu, Zhongjie
    Juan, Aimee
    Pei, Dorothy
    Hurst, Christian
    Chen, Jing
    Smith, Lois
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [34] SOCS3: What regulates the regulator?
    Pillemer, BBL
    Dixon-McCarthy, B
    Ostroukhova, M
    Podnar, A
    Oriss, T
    Ray, A
    FASEB JOURNAL, 2005, 19 (04): : A387 - A387
  • [35] IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3
    Croker, Ben A.
    Kiu, Hiu
    Metcalf, Donald
    O'Donnell, Joanne
    Cengia, Louise
    Alexander, Warren S.
    Roberts, Andrew W.
    CYTOKINE, 2010, 52 (1-2) : 4 - 4
  • [36] SOCS1 and SOCS3 in the control of CNS immunity
    Baker, Brandi J.
    Akhtar, Lisa Nowoslawski
    Benveniste, Etty N.
    TRENDS IN IMMUNOLOGY, 2009, 30 (08) : 392 - 400
  • [37] SOCS3 Phosphorylation In Myeloproliferative Neoplasms
    Arnold, Claire
    Elliott, Joanne
    Johnston, James A.
    McMullin, Mary Frances
    BLOOD, 2010, 116 (21) : 1271 - 1271
  • [38] SOCS3 promotor hypermethylation and STAT3-NF-κB interaction downregulate SOCS3 expression in human coronary artery smooth muscle cells
    Dhar, Kajari
    Rakesh, Kriti
    Pankajakshan, Divya
    Agrawal, Devendra K.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2013, 304 (06): : H776 - H785
  • [39] SOCS3 in liver regeneration and hepatocarcinoma
    Elliott, Joanne
    MOLECULAR INTERVENTIONS, 2008, 8 (01) : 19 - 21
  • [40] SOCS3 negatively regulates LIF signaling in neural precursor cells
    Emery, B
    Merson, TD
    Snell, C
    Young, KM
    Ernst, M
    Kilpatrick, TJ
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2006, 31 (04) : 739 - 747